(Q66392102)

English

A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine

clinical trial

Statements

A Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 (Galcanezumab) in Japanese Patients With Episodic Migraine (English)
0 references
0 references
9 November 2016
0 references
18 January 2019
0 references
451
0 references
18 year
0 references
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit